Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
6 p.m. Monday on WRAL: Find out why millions of your tax dollars sent to 868 private and religious schools across NC
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics Inc
(NQ:
IOVA
)
10.96
+0.46 (+4.33%)
Streaming Delayed Price
Updated: 3:32 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 16, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Looking Into Iovance Biotherapeutics's Recent Short Interest
August 16, 2024
Via
Benzinga
This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock
August 14, 2024
It could demonstrate a few capabilities that no other biotech has as of yet.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
Via
Benzinga
Iovance Biotherapeutics Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
August 12, 2024
Via
Benzinga
What the Options Market Tells Us About Iovance Biotherapeutics
August 08, 2024
Via
Benzinga
How Is The Market Feeling About Iovance Biotherapeutics?
July 22, 2024
Via
Benzinga
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
August 09, 2024
Via
Benzinga
Why Iovance Biotherapeutics Shares Are Soaring Today
August 09, 2024
The biopharma company is proving its recently approved cancer therapy is marketable.
Via
The Motley Fool
Why Is Iovance Bio (IOVA) Stock Up 18% Today?
August 09, 2024
Iovance Biotherapeutics stock is gaining as IOVA investors react to strong Q2 earnings beats and positive guidance for 2024 and 2025.
Via
InvestorPlace
Topics
Earnings
Exposures
Financial
Skin Cancer-Focused Iovance Biotherapeutics Reports Better-Than-Expected 2024, 2025 Outlook, Stock Surges
August 09, 2024
Iovance Biotherapeutics stock up 23.2% after issuing upbeat guidance for 2024 and 2025, beating Q2 earnings expectations.
Via
Benzinga
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
August 09, 2024
Via
Benzinga
IOVA Stock Earnings: Iovance Biotherapeutics Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
IOVA stock results show that Iovance Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
August 08, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
10 Best Small and Mid-Cap Stocks to Consider Buying in August
August 01, 2024
A shift in market dynamics could favor these 10 growth stocks.
Via
The Motley Fool
Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?
July 31, 2024
Find out how concerned investors should be about setbacks for this company's revolutionary new cancer therapies.
Via
The Motley Fool
Why Iovance Biotherapeutics Stock Stumbled Today
July 29, 2024
One pundit warns of apparent manufacturing issues with the company's melanoma drug.
Via
The Motley Fool
Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
July 29, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Price Forecast Slashed By 40% On Mutated Uptake For Its Newly Approved Skin Cancer Cell Therapy
July 29, 2024
Piper Sandler downgraded Iovance Biotherapeutics due to a slow launch of Amtagvi (lifileucel), a skin cancer treatment. Despite patient demand, extended treatment timelines and low infusion rates led...
Via
Benzinga
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
July 29, 2024
The Federal Reserve's fight against inflation may soon yield financial benefits.
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 29, 2024
Via
Benzinga
ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
July 28, 2024
Top mid-cap stocks of the week: ASTS up 47.88%, GSHD up 39.86%, VSAT up 30.78%, VKTX up 29.86%, BEAM up 23.93%, CLDX up 19.72%
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 23, 2024
Via
Benzinga
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 19, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
7 ‘Death Cross’ Stocks That Could Be Contrarian Buys
July 17, 2024
Although death cross stocks sound incredibly ominous, they could be the ideal time to consider a contrarian position.
Via
InvestorPlace
Is Iovance Biotherapeutics a Millionaire Maker?
July 14, 2024
This biotech's future is bright, but how good could it get for investors?
Via
The Motley Fool
3 Under-$10 Biotech Stocks That Could Make You Rich
July 11, 2024
Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis.
Via
InvestorPlace
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
July 11, 2024
Via
Benzinga
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
June 28, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Is It Too Late to Buy Iovance Biotherapeutics Stock?
June 28, 2024
The stock is down more than 50% from its 52-week high.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.